Zhigang Ji

4PUBLICATIONS
0CO-AUTHORS
Molecular targetsPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Jul 10, 2025
Malevolent alliance of MYBL2hi cancer stem cell and SPP1+ macrophage confers resistance to neoadjuvant immunotherapy in bladder cancer.

Hualin Chen, Zhaoheng Jin, Yueqiang Peng

|Jul 15, 2023
PLAGL2 promotes bladder cancer progression via RACGAP1/RhoA GTPase/YAP1 signaling.

Hualin Chen, Wenjie Yang, Yingjie Li

|Mar 11, 2023
Crosstalk between Mesenchymal Stem Cells and Cancer Stem Cells Reveals a Novel Stemness-Related Signature to Predict Prognosis and Immunotherapy Responses for Bladder Cancer Patients.

Lin Ma, Hualin Chen, Wenjie Yang

|Dec 23, 2022
Integrated Analysis Revealed an Inflammatory Cancer-Associated Fibroblast-Based Subtypes with Promising Implications in Predicting the Prognosis and Immunotherapeutic Response of Bladder Cancer Patients.

Hualin Chen, Wenjie Yang, Xiaoqiang Xue

Pageof 1

Frequent Collaborators